MENU
+Compare
ICCM
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$1.01
Change
-$0.00 (-0.00%)
Capitalization
54.88M

ICCM IceCure Medical Ltd Forecast, Technical & Fundamental Analysis

Icecure Medical Ltd is a commercial-stage medical device company... Show more

ICCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ICCM with price predictions
Jun 27, 2025

ICCM's RSI Indicator ascends from oversold territory

The RSI Indicator for ICCM moved out of oversold territory on June 24, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 36 similar instances when the indicator left oversold territory. In of the 36 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 27, 2025. You may want to consider a long position or call options on ICCM as a result. In of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ICCM just turned positive on June 25, 2025. Looking at past instances where ICCM's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ICCM advanced for three days, in of 186 cases, the price rose further within the following month. The odds of a continued upward trend are .

ICCM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICCM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ICCM entered a downward trend on June 27, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.021) is normal, around the industry mean (24.463). P/E Ratio (0.000) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (19.455) is also within normal values, averaging (43.062).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ICCM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICCM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
ICCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ICCM is expected to report earnings to fall 208.33% to -6 cents per share on August 18

IceCure Medical Ltd ICCM Stock Earnings Reports
Q2'25
Est.
$-0.06
Q1'25
Beat
by $0.14
Q4'24
Est.
$-0.08
Q3'24
Missed
by $0.01
Q2'24
Beat
by $0.01
The last earnings report on May 28 showed earnings per share of 5 cents, beating the estimate of -7 cents. With 232.07K shares outstanding, the current market capitalization sits at 54.88M.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
7 Haeshel Street
Phone
+972 46230333
Employees
46
Web
https://www.icecure-medical.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RDEIF17.36N/A
N/A
Redeia Corporacion SA
KRDXF307.07N/A
N/A
Kardex Holding AG
NORSF0.17N/A
N/A
NORSK TITANIUM AS
CNLTL30.00-0.01
-0.03%
Connecticut Light & Power Co. (The)
ENTEF0.02N/A
-2.29%
ESE Entertainment Inc.

ICCM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ICCM has been loosely correlated with AMBBY. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ICCM jumps, then AMBBY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICCM
1D Price
Change %
ICCM100%
-0.49%
AMBBY - ICCM
35%
Loosely correlated
N/A
JMPHF - ICCM
31%
Poorly correlated
N/A
SAFLF - ICCM
28%
Poorly correlated
N/A
PRPH - ICCM
28%
Poorly correlated
+7.06%
MGRM - ICCM
22%
Poorly correlated
+0.35%
More